Medtech companies look to post-pandemic home testing beyond COVID-19
First published on Encouraged by the development of rapid at-home coronavirus tests, medtech companies are now betting on the potential to sell over-the-counter and direct-to-consumer diagnostics for diseases beyond COVID-19. The pandemic has enabled consumers to get tested for the virus in the privacy of their homes, a convenience that companies like Abbott Laboratories and Quest Diagnostics are hoping will appeal to people when it comes to other diagnostics. Home testing was already rising worldwide, as consumers take a more proactive role in their healthcare. COVID-19 is likely speeding t...